(Q46932441)

26 December 2017

title

Pramipexole protects against MPTP toxicity in non-human primates (English)

1 reference

26 December 2017

author

Mahmoud M. Iravani

1

1 reference

26 December 2017

Anthony H V Schapira

5

object named as

Anthony H Schapira

1 reference

26 December 2017

J M Cooper

3

object named as

J Mark Cooper

1 reference

26 December 2017

author name string

Claire O Haddon

2

1 reference

26 December 2017

Peter Jenner

4

1 reference

26 December 2017

language of work or name

English

0 references

publication date

8 February 2006

1 reference

26 December 2017

Journal of Neurochemistry

published in

1 reference

26 December 2017

volume

96

1 reference

26 December 2017

issue

5

1 reference

26 December 2017

page(s)

1315-1321

1 reference

26 December 2017

Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03625.X

Molecular Pathways of Neurodegeneration in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03625.X

The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03625.X

Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03625.X

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03625.X

Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03625.X

A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03625.X

Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03625.X

Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03625.X

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03625.X

Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03625.X

Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03625.X

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03625.X

Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03625.X

Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2005.03625.X

10.1111/J.1471-4159.2005.03625.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017